A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LPA / lysophosphatidic acid

[Related PubMed/MEDLINE]
Total Number of Papers: 2509
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LPA  (>> Co-occurring Abbreviation)
Long Form:   lysophosphatidic acid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. CAFs, PDAC, PSCs
2019 Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity. ATX
2019 ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction. L-NAME, PVR, UPP, VE
2019 Autotaxin determines colitis severity in mice and is secreted by B cells in the colon. ---
2019 Autotaxin/lysophosphatidic acid signaling mediates obesity-related cardiomyopathy in mice and human subjects. ---
2019 Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner. C1P, HO-1, iNOS, LPC, S1P
2019 Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment. LPAR, PLA2
2019 Cholestatic pruritus : an update. ICP, MARS, PBC, SSRI
2019 HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells. HEB
10  2019 Identification and biochemical characterization of a second zebrafish autotaxin gene. ATX, KO, lysoPLD
11  2019 Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G0/G1 switch gene 2 (G0S2). ATGL, G0S2, LPAAT, LXR, TG
12  2019 Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia. CSF
13  2019 LPA Receptor 4 deficiency attenuates experimental atherosclerosis. ---
14  2019 LPA1 receptor activation induces PKCalpha nuclear translocation in glioblastoma cells. GBM
15  2019 LPAR2 and LPAR4 are the Main Receptors Responsible for LPA Actions in Ovarian Endometriotic Cysts. ATX, LPAR, PLA2
16  2019 Lysophosphatidic acid activates satellite glia cells and Schwann cells. ---
17  2019 Lysophosphatidic acid guides the homing of transplanted olfactory ensheathing cells to the lesion site after spinal cord injury in rats. OECs, SCI
18  2019 Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling. DN, Egr-1, KLF5, MAPKs
19  2019 Lysophosphatidic acid induces the crosstalk between the endovascular human trophoblast and endothelial cells in vitro. CM
20  2019 Lysophosphatidic acid precursor levels decrease and an arachidonic acid-containing phosphatidylcholine level increases in the dorsal root ganglion of mice after peripheral nerve injury. AA-PC, DRG, MALDI-IMS, PA, SNT
21  2019 Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-kappaB signaling and NADPH oxidase. DN, JNK, LPA1, STZ, TLR4
22  2019 Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer. BC, GSEA, LPAR6, LPAR6, qRT-PCR
23  2019 Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice. CNS, SCI
24  2019 Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential. OTP
25  2019 Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry. BSI, GPCRs, LP
26  2019 Modulation of urinary frequency via type 1 lysophosphatidic acid receptors: Effect of the novel antagonist ASP6432 in conscious rats. L-NAME
27  2019 Molecular mechanism of lysophosphatidic acid-induced hypertensive response. ---
28  2019 Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6. ACP6, FTEC, GOF, HGSOC
29  2019 Plasma lipidomic signatures of spontaneous obese rhesus monkeys. FFA, GC/MS, LPC, NAFLD, PC, PE, PG, PI, PS, SM, T2D, UPLC/MS
30  2019 Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder. ATX, ECT, MDD
31  2019 Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. ATX
32  2019 ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. CAMs, HAECs, MCP-1
33  2019 Serum autotaxin levels are associated with Graves' disease. ATX
34  2019 Targeting the Nav1.8 ion channel engenders sex-specific responses in lysophosphatidic acid-induced joint neuropathy. ---
35  2019 The role of lysophosphatidic acid in the physiology and pathology of the skin. EDG, HIF-1alpha, LPPs, MAPK, PI3K, PKC
36  2018 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies. GPCRs, LPLs, S1P
37  2018 2-O-Carba-oleoyl cyclic phosphatidic acid induces glial proliferation through the activation of lysophosphatidic acid receptor. 2ccPA, cPA, ERK, OPCs
38  2018 Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling. ---
39  2018 Activation of Lysophosphatidic Acid Receptor 3 Inhibits Megakaryopoiesis in Human Hematopoietic Stem Cells and Zebrafish. CD41, HSC, LPA2, LPA3, LPARs
40  2018 Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. ATX, HGSC, LPAR, OS, PFS
41  2018 Addition of high load of lysophosphatidic acid to standard and high-fat chows causes no significant changes of its circulating and peripheral tissue levels but affects body weight and visceral fat mass of mice. ---
42  2018 ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro. ADSCs, ATX, EpCAM, HMECs, LPAR1, MES, TNBC
43  2018 Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology. CYP19A1, EC, SRD5A2
44  2018 Altered synaptic phospholipid signaling in PRG-1 deficient mice induces exploratory behavior and motor hyperactivity resembling psychiatric disorders. PRG-1
45  2018 ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway. ATX, ER, ERK
46  2018 Autotaxin in Pathophysiology and Pulmonary Fibrosis. ATX, BALF, ENPP2, IPF, lysoPLD
47  2018 Autotaxin is a novel molecular identifier of type I endometrial cancer. ATX
48  2018 Autotaxin-beta interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis. ATX, SDC4
49  2018 Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism. ATX, HFHS
50  2018 Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes. AH, ATX, LPC
51  2018 Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease. AD, ATX, GPCRs
52  2018 Biofunctionalized Lysophosphatidic Acid/Silk Fibroin Film for Cornea Endothelial Cell Regeneration. CEnCs, LPA/SF, RT-PCR, SF
53  2018 Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy. ---
54  2018 Bovine ovarian follicular growth and development correlate with lysophosphatidic acid expression. ---
55  2018 c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis. JNK, MCs, mSin1, mTORC2
56  2018 Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure. LPP3
57  2018 Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. ATX, NASH
58  2018 Cholesterol inhibits entotic cell-in-cell formation and actomyosin contraction. Chol, PE, SA
59  2018 Co-stimulation of LPAR1 and S1PR1/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases. hADMSCs, IL, LPARs, NF-kappaB, S1P, S1PRs
60  2018 Deficiency of alkaline SMase enhances dextran sulfate sodium-induced colitis in mice with upregulation of autotaxin. Alk-SMase, DSS, IL, PAF
61  2018 Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications. FHBP, HA
62  2018 Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials. ATX, IPF, LPC
63  2018 Different agonists induce distinct single-channel conductance states in TRPV1 channels. ---
64  2018 Early development of porcine parthenogenetic embryos and reduced expression of primed pluripotent marker genes under the effect of lysophosphatidic acid. qRT-PCR
65  2018 Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation. LUTS/BPH, UPP
66  2018 Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary. ---
67  2018 Effects of LPA1 and LPA6 on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs. LPA1
68  2018 Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication. CSF, MS, RRMS
69  2018 Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis. FAK
70  2018 Expression of genes for enzymes synthesizing lysophosphatidic acid, its receptors and follicle developmental factors derived from the cumulus-oocyte complex is dependent on the ovarian follicle type in cows. AX, BMP15, COCs, CTSs, FST, GDF9, PLA2
71  2018 Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na+/H+ exchanger 3 by lysophosphatidic acid in vivo. NHE3
72  2018 Gintonin Attenuates D-Galactose-Induced Hippocampal Senescence by Improving Long-Term Hippocampal Potentiation, Neurogenesis, and Cognitive Functions. D-gal, LTP
73  2018 Gintonin, a ginseng-derived exogenous lysophosphatidic acid receptor ligand, enhances blood-brain barrier permeability and brain delivery. BBB, HBMECs
74  2018 Gintonin, a Ginseng-Derived Exogenous Lysophosphatidic Acid Receptor Ligand, Protects Astrocytes from Hypoxic and Re-oxygenation Stresses Through Stimulation of Astrocytic Glycogenolysis. ATP
75  2018 High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells. ATX, PCa, VEGF-C
76  2018 Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model. ATX, LPC
77  2018 Identification of potent lysophosphatidic acid receptor 5 (LPA5) antagonists as potential analgesic agents. BBB, HTS, LPA5
78  2018 Identification of Rice Koji Extract Components that Increase beta-Glucocerebrosidase Levels in Human Epidermal Keratinocytes. PA
79  2018 Identifying lysophosphatidic acid receptor subtype 1 (LPA1) as a novel factor to modulate microglial activation and their TNF-alpha production by activating ERK1/2. LPA1, LPA1, LPS, TACE
80  2018 In vitro evaluation of lysophosphatidic acid delivery via reverse perfluorocarbon emulsions to enhance alveolar epithelial repair. ---
81  2018 In vivo evidence for possible up-regulating roles of lysophosphatidic acid around fertilization in rats. ATX, COCs
82  2018 Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma. ATX, HCF
83  2018 Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis. ECs
84  2018 Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells. PDBu, TPA
85  2018 Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells. ---
86  2018 Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain. L-AA, NeuP, PSNL
87  2018 Lipidomic analysis of plasma lipids composition changes in septic mice. Cer, DG, FA, LPC, LPE, MG, PA, PC, PE, PI, SM, TG
88  2018 Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges. ---
89  2018 LPA Induces Keratinocyte Differentiation and Promotes Skin Barrier Function through the LPAR1/LPAR5-RHO-ROCK-SRF Axis. AD, proFLG
90  2018 LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. ---
91  2018 LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. GBM, LPAR1
92  2018 LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2. ERM, LPARs
93  2018 LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer. ATX, CRT, eIF2alpha, PCa, ROS, VEGF
94  2018 LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model. ---
95  2018 Lysophosphatidic acid accelerates development of porcine embryos by activating formation of the blastocoel. BCL2L1
96  2018 Lysophosphatidic acid acts on LPA1 receptor to increase H2 O2 during flow-induced dilation in human adipose arterioles. CAD, FID
97  2018 Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo. micro-CT
98  2018 Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier. CNS, TCA
99  2018 Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice. CNS, GPCRs, LPA1, pCREB
100  2018 Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesis. ---